Nearly a decade after losing a bidding war for device maker Guidant to Boston Scientific (NYSE:BSX), Johnson & Johnson (NYSE:JNJ) finally has a chance for payback at a multibillion-dollar trial set to begin tomorrow.
A federal judge in New York will hear the case without a jury and decide whether Guidant, through its successor Boston Scientific, should be held liable for breaching a contract with J&J.
Help employers find you! Check out all the jobs and post your resume.
A federal judge in New York will hear the case without a jury and decide whether Guidant, through its successor Boston Scientific, should be held liable for breaching a contract with J&J.
Help employers find you! Check out all the jobs and post your resume.
